Skip to Main Content

Paper Details

Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.
Nat Commun
5
2023
Author NameAffiliation
Caitlin M O'ConnorUniversity of Michigan ann arbor
Caitlin M O'ConnorRogel Cancer Center, University of Michigan ann arbor
Jaya SangodkarUniversity of Michigan ann arbor
Jaya SangodkarRogel Cancer Center, University of Michigan ann arbor
Jaya SangodkarUniversity of Michigan ann arbor
Jaya SangodkarRogel Cancer Center, University of Michigan ann arbor
Javed SiddiquiDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School ann arbor
Javed SiddiquiMichigan Center for Translational Pathology, University of Michigan ann arbor
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Derek J TaylorDepartment of Biochemistry Case Western Reserve University School of Medicine
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf
Marcin CieslikDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School ann arbor
Marcin CieslikMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanDepartment of Pathology and Rogel Cancer Center, University of Michigan Medical School ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Goutham NarlaUniversity of Michigan ann arbor
Goutham NarlaRogel Cancer Center, University of Michigan ann arbor
Goutham NarlaUniversity of Michigan ann arbor
Goutham NarlaRogel Cancer Center, University of Michigan ann arbor
  • 1 - 21

Datasets